Fingerprint
Dive into the research topics where Hossam Hammouda Nada is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Design and validation of the first-in-class PROTACs for targeted degradation of the immune checkpoint LAG-3
Vázquez, N. G., Abdel-Rahman, S. A., Nada, H. & Gabr, M., 1 Jan 2026, In: Bioorganic and Medicinal Chemistry Letters. 130, 130428.Research output: Contribution to journal › Article › peer-review
-
Discovery and validation of LAGi-DEL: A nanomolar LAG-3 inhibitor that reverses immune suppression in tumor-immune co-culture models
Nada, H., Calvo-Barreiro, L., Abdel-Rahman, S. A. & Gabr, M. T., 5 Jan 2026, In: European Journal of Medicinal Chemistry. 301, 118204.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Discovery of small molecule CHI3L1 inhibitors by SPR-based high-throughput screening
Zhang, L., Hammouda, H. H. N. & Gabr, M. T., 1 Feb 2026, In: Bioorganic and Medicinal Chemistry Letters. 131, 130460.Research output: Contribution to journal › Article › peer-review
-
Overcoming the undruggable barrier: Structure-guided discovery of a potent small molecule CD28 antagonist with translational potential
Upadhyay, S., Nada, H., Cho, S. & Gabr, M. T., Jan 2026, In: Biomedicine and Pharmacotherapy. 194, 118937.Research output: Contribution to journal › Article › peer-review
Open Access -
TREM2 activation by first-in-class direct small molecule agonists: DEL screening, optimization, biophysical validation, and functional characterization
Nada, H., Yuan, S., El Gaamouch, F., Cho, S., Kuncewicz, K., Calvo-Barreiro, L. & Gabr, M. T., 15 Jan 2026, In: European Journal of Medicinal Chemistry. 302, 118358.Research output: Contribution to journal › Article › peer-review
Open Access